Loading…
Smoking Attributable Risk in Multiple Sclerosis
Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including in...
Saved in:
Published in: | Frontiers in immunology 2022-03, Vol.13, p.840158-840158 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793 |
---|---|
cites | cdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793 |
container_end_page | 840158 |
container_issue | |
container_start_page | 840158 |
container_title | Frontiers in immunology |
container_volume | 13 |
creator | Manouchehrinia, Ali Huang, Jesse Hillert, Jan Alfredsson, Lars Olsson, Tomas Kockum, Ingrid Constantinescu, Cris S |
description | Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number. |
doi_str_mv | 10.3389/fimmu.2022.840158 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_843164962253481d9e560fd09845994a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_843164962253481d9e560fd09845994a</doaj_id><sourcerecordid>2641515051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</originalsourceid><addsrcrecordid>eNpVUU1P3DAQtSoqQJQfwAXtsZcstmfs2BckhKBFAlUq3C0ndrZm87G1E1D_fb1kQawvHr15781oHiFnjC4BlL5oQtdNS045XyqkTKgv5JhJiQVwjgef6iNymtIzzQ81AIhDcgQCqAZKj8nFYzesQ79aXI1jDNU02qr1i98hrRehXzxM7Rg2GXisWx-HFNI38rWxbfKnu_-EPN3ePF3_LO5__bi7vrovagQYCw_KqZq7WpcCGlc6zvN467WrKgrgsPFYAqO0EhorxUHUyLV36JWCUsMJuZtt3WCfzSaGzsZ_ZrDBvAFDXBkbx5C3MgqBSdSScwGomNNeSNo4qhUKrdFmr2L2Sq9-M1V7bjtonStvUKCUPPMvZ37udN7Vvh-jbfdk-50-_DGr4cUozUsKMht83xnE4e_k02i6kGrftrb3w5QMl8gEE1SwTGUztc7XTdE3H2MYNduYzVvMZhuzmWPOmvPP-30o3kOF_8wIouM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641515051</pqid></control><display><type>article</type><title>Smoking Attributable Risk in Multiple Sclerosis</title><source>Open Access: PubMed Central</source><creator>Manouchehrinia, Ali ; Huang, Jesse ; Hillert, Jan ; Alfredsson, Lars ; Olsson, Tomas ; Kockum, Ingrid ; Constantinescu, Cris S</creator><creatorcontrib>Manouchehrinia, Ali ; Huang, Jesse ; Hillert, Jan ; Alfredsson, Lars ; Olsson, Tomas ; Kockum, Ingrid ; Constantinescu, Cris S</creatorcontrib><description>Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2022.840158</identifier><identifier>PMID: 35309300</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>attributable fraction ; Case-Control Studies ; Female ; Humans ; Immunology ; Male ; multiple sclerosis ; Multiple Sclerosis - etiology ; Multiple Sclerosis - genetics ; risk factor ; Risk Factors ; smoking ; Smoking - adverse effects ; Smoking - epidemiology ; tobacco ; Tobacco Smoking - adverse effects ; Tobacco Smoking - epidemiology</subject><ispartof>Frontiers in immunology, 2022-03, Vol.13, p.840158-840158</ispartof><rights>Copyright © 2022 Manouchehrinia, Huang, Hillert, Alfredsson, Olsson, Kockum and Constantinescu.</rights><rights>Copyright © 2022 Manouchehrinia, Huang, Hillert, Alfredsson, Olsson, Kockum and Constantinescu 2022 Manouchehrinia, Huang, Hillert, Alfredsson, Olsson, Kockum and Constantinescu</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</citedby><cites>FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927036/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927036/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35309300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:149162211$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Manouchehrinia, Ali</creatorcontrib><creatorcontrib>Huang, Jesse</creatorcontrib><creatorcontrib>Hillert, Jan</creatorcontrib><creatorcontrib>Alfredsson, Lars</creatorcontrib><creatorcontrib>Olsson, Tomas</creatorcontrib><creatorcontrib>Kockum, Ingrid</creatorcontrib><creatorcontrib>Constantinescu, Cris S</creatorcontrib><title>Smoking Attributable Risk in Multiple Sclerosis</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number.</description><subject>attributable fraction</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Immunology</subject><subject>Male</subject><subject>multiple sclerosis</subject><subject>Multiple Sclerosis - etiology</subject><subject>Multiple Sclerosis - genetics</subject><subject>risk factor</subject><subject>Risk Factors</subject><subject>smoking</subject><subject>Smoking - adverse effects</subject><subject>Smoking - epidemiology</subject><subject>tobacco</subject><subject>Tobacco Smoking - adverse effects</subject><subject>Tobacco Smoking - epidemiology</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUU1P3DAQtSoqQJQfwAXtsZcstmfs2BckhKBFAlUq3C0ndrZm87G1E1D_fb1kQawvHr15781oHiFnjC4BlL5oQtdNS045XyqkTKgv5JhJiQVwjgef6iNymtIzzQ81AIhDcgQCqAZKj8nFYzesQ79aXI1jDNU02qr1i98hrRehXzxM7Rg2GXisWx-HFNI38rWxbfKnu_-EPN3ePF3_LO5__bi7vrovagQYCw_KqZq7WpcCGlc6zvN467WrKgrgsPFYAqO0EhorxUHUyLV36JWCUsMJuZtt3WCfzSaGzsZ_ZrDBvAFDXBkbx5C3MgqBSdSScwGomNNeSNo4qhUKrdFmr2L2Sq9-M1V7bjtonStvUKCUPPMvZ37udN7Vvh-jbfdk-50-_DGr4cUozUsKMht83xnE4e_k02i6kGrftrb3w5QMl8gEE1SwTGUztc7XTdE3H2MYNduYzVvMZhuzmWPOmvPP-30o3kOF_8wIouM</recordid><startdate>20220303</startdate><enddate>20220303</enddate><creator>Manouchehrinia, Ali</creator><creator>Huang, Jesse</creator><creator>Hillert, Jan</creator><creator>Alfredsson, Lars</creator><creator>Olsson, Tomas</creator><creator>Kockum, Ingrid</creator><creator>Constantinescu, Cris S</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20220303</creationdate><title>Smoking Attributable Risk in Multiple Sclerosis</title><author>Manouchehrinia, Ali ; Huang, Jesse ; Hillert, Jan ; Alfredsson, Lars ; Olsson, Tomas ; Kockum, Ingrid ; Constantinescu, Cris S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>attributable fraction</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Immunology</topic><topic>Male</topic><topic>multiple sclerosis</topic><topic>Multiple Sclerosis - etiology</topic><topic>Multiple Sclerosis - genetics</topic><topic>risk factor</topic><topic>Risk Factors</topic><topic>smoking</topic><topic>Smoking - adverse effects</topic><topic>Smoking - epidemiology</topic><topic>tobacco</topic><topic>Tobacco Smoking - adverse effects</topic><topic>Tobacco Smoking - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manouchehrinia, Ali</creatorcontrib><creatorcontrib>Huang, Jesse</creatorcontrib><creatorcontrib>Hillert, Jan</creatorcontrib><creatorcontrib>Alfredsson, Lars</creatorcontrib><creatorcontrib>Olsson, Tomas</creatorcontrib><creatorcontrib>Kockum, Ingrid</creatorcontrib><creatorcontrib>Constantinescu, Cris S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manouchehrinia, Ali</au><au>Huang, Jesse</au><au>Hillert, Jan</au><au>Alfredsson, Lars</au><au>Olsson, Tomas</au><au>Kockum, Ingrid</au><au>Constantinescu, Cris S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Smoking Attributable Risk in Multiple Sclerosis</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2022-03-03</date><risdate>2022</risdate><volume>13</volume><spage>840158</spage><epage>840158</epage><pages>840158-840158</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We conducted a matched case-control study, including individuals with MS and population-based controls. Overall, sex- and genetic risk score-stratified AF due to smoking were calculated by fitting logistic regression models. We included 9,419 individuals with MS and 9,419 population-based matched controls. At the time of MS onset 44.1% of persons with MS and 35.9% of controls ever regularly smoked of which 38.1% and 29.2% were still smoking. The overall AF was 13.1% (95%CI: 10.7 to 15.4). The AF was 10.6% (95%CI: 7.4 to 13.7) in females and 19.1% (95%CI: 13.1 to 25.1) in males. The AF was 0.6% (95%CI: 0.0 to 2) in ex-smokers. In those having human leucocyte antigen (HLA) and non-HLA risk scores above the median levels of controls, the AF was 11.4% (95%CI: 6.8 to 15.9) and 12% (95%CI: 7.7 to 16.3), respectively. The AF was 17.6% (95%CI: 10.2 to 24.9) and 18.6% (95%CI: 5.5 to 31.6) in those with HLA and non-HLA risk scores below the median levels in controls, respectively. We noticed a decline in AF in recent birth cohorts. This study indicates that at least 13% of cases of MS could be prevented through the avoidance of tobacco smoking. Considering the prevalence of MS, this represents a very large group of people in absolute number.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35309300</pmid><doi>10.3389/fimmu.2022.840158</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2022-03, Vol.13, p.840158-840158 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_843164962253481d9e560fd09845994a |
source | Open Access: PubMed Central |
subjects | attributable fraction Case-Control Studies Female Humans Immunology Male multiple sclerosis Multiple Sclerosis - etiology Multiple Sclerosis - genetics risk factor Risk Factors smoking Smoking - adverse effects Smoking - epidemiology tobacco Tobacco Smoking - adverse effects Tobacco Smoking - epidemiology |
title | Smoking Attributable Risk in Multiple Sclerosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Smoking%20Attributable%20Risk%20in%20Multiple%20Sclerosis&rft.jtitle=Frontiers%20in%20immunology&rft.au=Manouchehrinia,%20Ali&rft.date=2022-03-03&rft.volume=13&rft.spage=840158&rft.epage=840158&rft.pages=840158-840158&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2022.840158&rft_dat=%3Cproquest_doaj_%3E2641515051%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-e38d8c2dc9753fd7d22004ae9dbb033d4fe473100b594b8235c429ed4e883793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2641515051&rft_id=info:pmid/35309300&rfr_iscdi=true |